The majority of individuals infected with human immunodeficiency virus (HIV) receiving antiretroviral therapy (ART) suppress HIV plasma viremia for significant periods of time [1] . Nonetheless, eradication of HIV by ART alone has not been achieved, likely in part due to the persistence of infected cells in peripheral blood and tissues [2] . In particular, it has been demonstrated that a pool of latently infected CD4 + T cells persists in virtually all infected individuals receiving ART for prolonged periods of time, and it has been suggested that the existence of this pool of cells is one of the major obstacles to achieving eradication of virus [2] . In order to eliminate the latent viral reservoir, a therapeutic strategy aimed at deliberately inducing HIV expression in infected cells has been proposed [2] . Such a strategy hypothesizes that "purging" agents could stimulate HIV expression in the latent viral reservoir and lead to elimination of infected cells via virus-induced cytopathic effects while preventing spread of infection by ART [2] . Indeed, nearly a decade ago, it was demonstrated that intermittent administration of interleukin 2 (IL-2) could reduce the infectious HIV burden in patients receiving ART [3] . However, administration of IL-2 [3] or anti-CD3 antibody, a potent T-cell stimulator [4] , did not lead to eradication of HIV in infected individuals receiving ART; the treatment failed to prevent plasma viral rebound upon cessation of antiretroviral drugs [5] . Subsequently, a number of studies have addressed the molecular mechanisms of HIV persistence and have suggested that repression of chromatin structure may play a role in inhibition of viral transcription [2] . More recently, it has been shown in vitro that inhibitors of histone deacetylases (HDACis) promote acetylation and remodeling of the chromatin structure, which in turn allow expression of HIV RNA to occur [6] . Among HDACis, valproic acid (VPA), a drug clinically used to treat epilepsy and bipolar disorder, has been tested in humans as a potential virus "purging" agent and was shown in one study to diminish the size of the latent viral reservoir in infected individuals receiving ART [7] .
However, subsequent studies have demonstrated no appreciable reduction of the latent viral reservoir following treatment with VPA [6, 8, 9] . Suberoylanilide hydroxamic acid (SAHA), another HDACi, has been shown to induce HIV expression in several in vitro and ex vivo systems [6, 10] . Given these conflicting results and considering the fact that a major thrust of HIV therapeutic research at the present time is the development of strategies for eradicating virus, it is of considerable interest and importance to carefully evaluate the capacity of HDACis to induce HIV expression in the latent viral reservoir of infected individuals receiving ART. We conducted the present study to address this issue.
METHODS

Clinical Samples
Twenty-seven HIV-infected individuals receiving ART for a median of 2 years were included in this study ( 
Quantitation of Cell-Free HIV
The copy number of virion-associated HIV RNA in the cell culture supernatants was determined using the Cobas Ampliprep/Cobas Taqman HIV-1 Test, version 2.0 (Roche Diagnostics) following 48 hours of incubation of cells with the above compounds. The limit of detection for this system is 20 copies/mL.
Quantitation of HIV Proviral DNA
To determine the frequency of resting CD4 + T cells carrying HIV DNA, real-time polymerase chain reaction (PCR) was performed on genomic DNA isolated from resting CD4 + T cells (Qiagen), as described elsewhere [11] . 
Flow Cytometric Analysis
In order to assess the level of cellular activation, resting CD4 + T cells in each culture condition were stained with anti-CD25, CD69, HLA-DR, and Ki67 antibody (BD Biosciences) and analyzed using a FACS Canto (BD Biosciences) and FlowJo software.
Heteroduplex Mobility Assay
To examine the degree of heterogeneity of virion-associated HIV RNA, heteroduplex mobility assay (HMA) was performed as described elsewhere [12] using cell-free culture supernatants. Briefly, HIV env (C2-V5) was amplified by nested RT-PCR using primers specific for HIV-1 envelope (ED5/ ED12 and DR7/DR8). PCR products were then denaturated at 94°C for 2 minutes, reannealed by cooling on ice in annealing buffer, subjected to 5% polyacrylamide gel, and visualized by ethidium bromide.
Statistical Analysis
The Wilcoxon signed rank test was used to compare paired data. Correlations were determined by the Spearman rank method. The Bonferroni method was used to adjust P values for multiple testing.
RESULTS
To determine the degree and extent to which HDACis induce HIV expression in the latent viral reservoir, we isolated resting CD4 + T cells from 27 aviremic HIV-infected individuals receiving ART (Table 1) and incubated the cells with various HDACis and T-cell mitogens in the presence of antiretroviral drugs. We used 3 different HDACis, 2 of which are clinically approved for use in humans (VPA and SAHA), and oxamflatin, a hydroxamic acid selective for class I HDACs [13] . In addition, a protein kinase C agonist, prostratin [14] , or anti-CD3 antibody were used as positive controls. Cell culture media was used as a negative control. First, we investigated whether HDACis increase the level of cellular activation in resting CD4 + T cells. As shown in Figure 1A , incubation of resting CD4 + T cells with each of 3
HDACis did not result in upregulation of the cellular activation markers CD25, CD69, HLA-DR, and Ki-67 compared with cells cultured in media alone. In contrast, stimulation with prostratin and anti-CD3 dramatically increased the expression of these activation markers. Next, we measured the copy number of virion-associated HIV RNA in the culture supernatants of cells following incubation with media alone, HDACis, or T-cell activators ( Figure 1B ). In the majority of HIV-aviremic individuals receiving ART, HIV RNA were not detected when cells were incubated with media alone (median, 19 copies per mL; interquartile range, 19-27), VPA (median, 19; interquartile range, Figure 1C ). There was a correlation between the level of HIV DNA in resting CD4 + T cells and the copy number of virion-associated HIV RNA in the cultures stimulated with either prostratin or anti-CD3 antibody (P = .02 and .02, respectively). However, no correlation was found between levels of HIV DNA in resting CD4 + T cells and the copy number of virion-associated HIV RNA in the cultures containing media alone or in those containing HDACis ( Figure 1C ). Finally, we investigated the degree of heterogeneity of virion-associated HIV RNA in the culture supernatants upon incubation of resting CD4 + T cells with HDACis versus T-cell activating reagents. We isolated virion-associated HIV RNA from the HDACi-containing cultures (>100 copies) followed by amplification of C2-V5 region of the HIV envelope gene. The PCR products were then denatured and reannealed, resulting in the formation of homo-and/or heteroduplexes based on the degree of sequence heterogeneity. As shown in Figure 1D , the HIV env obtained after incubating the cells with prostratin and anti-CD3 antibody showed high levels of heterogeneity, likely a result of maximal stimulation of HIV expression in cells carrying inducible virus. In contrast, the HIV env originating from the resting CD4 + T-cell culture stimulated with HDACis showed relatively low degrees of heterogeneity, suggesting that HDACis may only stimulate HIV expression in a small fraction of latently infected, resting CD4 + T cells.
DISCUSSION
It has been firmly established that the persistence of latent viral reservoir is one of the major obstacles to eradicating HIV in infected individuals receiving ART [2] . To accelerate the decay of the latent viral reservoir, a strategy aimed at deliberately stimulating cells harboring replication-competent virus in the presence of antiretroviral drugs has been considered as a promising approach [2] . Despite the earlier observations that T-cell-activating agents, such as IL-2 and anti-CD3 antibody, did not succeed in completely clearing HIV in patients receiving ART [3, 4] , a sustained effort has been directed in recent years toward testing newer agents that can induce HIV replication from the latent viral reservoir [2] . In particular, it has been suggested that VPA may lower the frequency of resting CD4 + T cells carrying infectious HIV in aviremic individuals by purging virus while avoiding toxicities associated with a polyclonal activation approach [7] . However, follow-up studies were inconsistent with the earlier finding and demonstrated no measurable efficacy when VPA was given to aviremic individuals [6, 8, 9] . Subsequently, SAHA was proposed as a virus purging agent on the basis of results obtained using cell lines and cells from infected individuals using a combination of HDACis and T-cell-stimulating agents [10, 15] . However, there have been only limited data directly addressing the degree and extent of HIV expression in HDACi-treated, highly purified resting CD4 + T cells from a large number of aviremic individuals. In the present study, we demonstrated that the overall levels of virion production by HDACi-stimulated resting CD4 + T cells are not statistically different from those of cells incubated with media alone. We chose to quantify the copy number of virion-associated HIV RNA instead of cell-associated HIV RNA because intracellular expression of HIV transcripts may not necessarily equate to production of viral particles; furthermore, virus-induced cytopathic effects would only occur following robust production of virions in latently infected cells. In addition, there was a lack of correlation between the frequency of cells carrying HIV DNA and the level of HDACi-induced virion production by the latent viral reservoir. These data suggest that HDACis would likely be ineffective at eliminating the latent viral reservoir in infected individuals receiving ART. Finally, we demonstrated that the quasi-species of HDACi-induced virions carried relatively homogeneous HIV env compared with that of virions collected from maximally stimulated cells. This finding indicates that HDACis, when they do induce virus production, may do so from only a restricted fraction of infected cells. It is also important to point out that ongoing HIV replication may occur in various tissue compartments in infected individuals receiving effective ART (<50 copies/mL) [11] . Under such circumstances, the administration of HDACis may not be able to eliminate persistently infected CD4 + T cells in aviremic individuals as these cells are already producing HIV. The quest for eradication of HIV in infected individuals receiving ART remains an ongoing challenge for the AIDS research community. Despite extraordinary effort and interest in using HDACis to eliminate the latent viral reservoir in HIVinfected individuals, it is likely that alternative therapeutic strategies that incorporate HIV-specific targeting and/or more targeted immune activation will be necessary to clear cellular reservoirs of virus.
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